Core Viewpoint - *ST Tianyu is facing significant challenges, including a criminal investigation into its actual controller for fund misappropriation, a series of executive resignations, and the risk of delisting due to negative audit opinions on internal controls and financial statements [1][2][10][11]. Group 1: Criminal Investigation - The company received a notice from the Wuhan Public Security Bureau regarding a criminal investigation into its actual controller, Yan Chunyu, for suspected fund misappropriation [2]. - The investigation meets the standards for criminal case filing as per Chinese law [2]. Group 2: Executive Resignations - Recent resignations include Chairman Yang Haitao, Director Eddie, and Vice General Manager and CFO Zhang Yanju, among others, citing personal reasons [5][6][7]. - The company has seen a significant drop in shareholding by its major shareholder, Wuhan Tongyu, from 24.58% to 12.45% [8]. Group 3: Delisting Risk - *ST Tianyu's stock is under additional risk warnings due to a negative audit report on its internal controls for the fiscal year 2024 [10]. - The company has been issued a delisting risk warning due to an audit report that could not express an opinion on its financial statements [11]. - The company is actively working to improve its internal control systems and audit supervision to mitigate these risks [10][11].

Core Points - ST New Wave (600777) announced that it cannot disclose the 2024 annual report and the 2025 Q1 report within the statutory deadline due to the need for further supplementary financial information [1] - The company's stock will be suspended from trading starting May 6, 2025 [1] - If the company fails to disclose the 2024 annual report within two months of the stock suspension, it will face delisting risk warnings and may resume trading [1] - If the company does not disclose a majority of the board's assurance of the authenticity, accuracy, and completeness of the 2024 annual report within two months of the delisting risk warning, there is a risk of termination of listing by the Shanghai Stock Exchange [1]

证券代码：600200 证券简称：*ST 苏吴 公告编号：临 2025-046 江苏吴中医药发展股份有限公司 关于立案调查进展暨风险提示公告 本公司董事会及董事会全体成员保证公告内容不存在虚假记载、误导性陈 述或者重大遗漏，并对其内容的真实、准确和完整承担法律责任。 重要风险提示： 公司于 2025 年 2 月 27 日披露了《江苏吴中医药发展股份有限公司关于收到 中国证券监督管理委员会立案告知书暨风险提示公告》 因公司涉嫌信息披露违法违规，根据《中华人民共和国证券法》《中华人民共和 国行政处罚法》等法律法规，中国证监会决定对公司立案。 截至本公告披露日，中国证监会的调查尚在进行中，公司尚未收到就上述立 案调查事项的结论性意见或决定。在立案调查期间，公司积极配合中国证监会的 相关调查工作。 若后续经中国证监会行政处罚认定的事实，触及《上海证券交易所股票上市 规则》规定的重大违法强制退市情形，公司股票将被实施重大违法强制退市。请 投资者理性投资，注意投资风险。 公司目前日常生产经营正常，市场环境或行业政策未发生其他重大变化。公 司郑重提醒广大投资者，公司指定信息披露媒体为《中国证券报》《上海证券报》 及上海证券 ...

Core Viewpoint - Tianye Co., Ltd. (832023) disclosed a non-standard audit opinion for its 2024 annual report, indicating potential financial fraud and risks of delisting [1][10][14] Financial Performance Summary - In the 2024 annual performance report, the net profit attributable to the parent company was revised to 9.65 million yuan, a decrease of 1.89 million yuan or 66.22% from the previous estimate [2] - The company's operating income for 2024 was 493.55 million yuan, a slight increase of 7.34% compared to 2023, but the gross profit margin fell to 20.52% from 21.68% [9] - The net profit attributable to shareholders dropped by 71.07% compared to 2023, indicating a significant decline in profitability [9] Audit Findings - The audit report revealed several issues, including uncollectible sales revenue of 16.02 million yuan and inflated procurement costs of 8.55 million yuan, raising doubts about the authenticity of financial statements [10][11][12] - The internal control audit received a negative opinion, highlighting major deficiencies in the company's internal controls, which could lead to delisting risks [14][17] Internal Control Issues - The internal control report identified that management bypassed internal controls, leading to failures in key control points [14] - Specific deficiencies included improper procurement practices, such as inflated purchase amounts and lack of proper documentation for transactions [15][16] - The company has not corrected prior accounting errors, further complicating the reliability of its financial reporting [17]

Core Viewpoint - *ST Zhongcheng (formerly Qingdao Zhongcheng) has exhibited systematic, persistent, and cross-border characteristics in its financial fraud activities since 2017, involving fabricated projects and inflated asset values across two continents in the renewable energy and mineral resources sectors [1][2]. Group 1: Financial Fraud Details - The company inflated revenue by 1.403 billion yuan (92.18% of revenue) and profit by 553 million yuan (136.17% of profit) through premature recognition of uncompleted engineering income in the Philippines wind power project from 2017 to 2021 [1]. - In 2019, the company manipulated its financials by reducing revenue by 672 million yuan (88.83% of revenue) to adjust profit indicators, showcasing a typical "big bath" accounting strategy [1]. - From 2020 to 2022, despite knowing the revocation of mining rights and expiration of mining licenses, the company falsely listed invalid mining rights as intangible assets, cumulatively inflating asset size by over 1 billion yuan [2]. Group 2: Concealment of Major Litigation - In 2023, the company concealed a significant lawsuit involving 627 million yuan (57.47% of 2022 net assets) for six months, with collective participation from senior management in information suppression, indicating "institutional fraud" [3]. - The regulatory response included a fine of 7.5 million yuan for the company and a 6.5 million yuan fine plus a 10-year market ban for the main responsible person, totaling 19 million yuan in penalties, reflecting a shift towards a comprehensive punitive system [3]. Group 3: Potential Delisting - The delisting path for *ST Zhongcheng is characterized by intersecting regulatory triggers, including a negative net asset warning by the end of 2023 and a qualified audit report in 2024, which could lead to termination of listing [4]. - The company has faced compounded delisting risks due to six consecutive years of fraud, meeting the criteria for "three years of fraud leading to delisting" [4]. - Despite efforts from Qingdao state-owned assets to stabilize the company, including a debt waiver of 850 million yuan, the company still reported a 70.21% year-on-year revenue decline to 137 million yuan and a net loss of 310 million yuan in 2024, highlighting management failures in cross-border resource development [4].

Group 1: Company Performance and Risk Management - The company aims to consolidate existing business and clients while actively developing new ones to improve performance and avoid delisting risks [1][2] - Measures are being taken to enhance internal control management and ensure sustainable operational capabilities to eliminate delisting risks [2] - The company is optimistic about achieving a revenue target of 300 million this year despite restrictions on military procurement [2] Group 2: Strategic Planning and Investments - The company is exploring acquisition opportunities to mitigate the impact of the suspension of operations at its subsidiary, Dajiang Metal [3] - There are ongoing discussions regarding potential mergers and acquisitions that will be disclosed in accordance with regulatory requirements [4] - The company is committed to providing updates on any relevant acquisition targets as they arise [3][4] Group 3: Financial Outlook and Reporting - The company is focused on improving its gross profit margins, particularly in the metal products sector, to enhance overall performance [4] - Future plans and restructuring efforts will be communicated through official channels, ensuring transparency with investors [4]

证券代码：600190/900952 证券简称：*ST 锦港/*ST 锦港 B 公告编号：2025-050 锦州港股份有限公司 关于公司可能存在因股价低于1元而终止上市的 ?锦州港股份有限公司（以下简称"公司"）股票 2025 年 5 月 19 日收盘价 已连续 10 个交易日低于 1 元，其中 A 股收盘价为 0.92 元/股，B 股收盘价为 0.047 美元/股。根据《上海证券交易所股票上市规则》 （以下简称"《股票上市规则》"） 第 9.2.1 条第一款第三项规定，在上海证券交易所（以下简称"上交所"）既发 行 A 股股票又发行 B 股股票的上市公司，如果 A、B 股股票连续 20 个交易日的每 日股票收盘价均低于 1 元，公司股票可能被上交所终止上市交易，属于交易类强 制退市。根据《股票上市规则》第 9.6.1 条第二款规定，交易类强制退市公司股 票不进入退市整理期交易。敬请广大投资者注意投资风险。 ?公司于 2025 年 4 月 29 日收到中国证券监督管理委员会（以下简称"中国 证监会"）《行政处罚及市场禁入事先告知书》（【2025】1 号，以下简称"《事先 告知书》"），显示公司触及重大违法强制 ...

证券代码：600190/900952 证券简称：*ST锦港/*ST锦港B 公告编号：2025-051 锦州港股份有限公司 关于实施其他风险警示的进展公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重大风险提示： ?截至本公告披露日，锦州港股份有限公司（以下简称"公司"）存在三种 叠加实施其他风险警示的情形：一是，公司存在违规对外提供担保且未能在 1 个 月内完成整改的情形；二是，中审众环会计师事务所（特殊普通合伙）（以下简 称"中审众环"）对公司 2024 年度财务报告内部控制出具了否定意见的审计报告； 三是，根据中国证监会《行政处罚及市场禁入事先告知书》（处罚字【2024】59 号）及《行政处罚决定书》(〔2024〕96 号)载明的事实，公司披露的 2018 年至 条第（一）、 （三）、 （七）项规定的其他风险警示情形，公司股票已被上交所叠加 实施其他风险警示。 ?公司于2025年4月29日收到中国证券监督管理委员会（以下简称"中国证监 会"） 《行政处罚及市场禁入事先告知书》 （【2025】1号，以下简称" 截至本公 ...

证券代码：600200 证券简称：*ST苏吴 公告编号：临2025-040 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈 述或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 公司存在两种叠加实施其他风险警示的情形。一是公司 2024 年度财务报告 内部控制被年审机构出具无法表示意见；二是浙江复基控股集团有限公司的其他 关联方企业存在非经营性占用公司资金的情形。上述事项触及《上海证券交易所 股票上市规则》第 9.8.1 条第（一）（三）项的规定，公司被叠加实施其他风险 警示。 四、董事长被立案调查事项 重要风险提示： ? 公司存在重大违法强制退市风险。江苏吴中医药发展股份有限公司（以 下简称"公司"）于 2025 年 2 月 26 日收到中国证券监督管理委员会（以下简称 "中国证监会"）下发的《立案告知书》（证监立案字 0392025006 号），若后 续经中国证监会行政处罚认定的事实，触及《上海证券交易所股票上市规则》规 定的重大违法强制退市情形，公司股票将被实施重大违法强制退市。 ? 公司控股股东关联方存在大额资金占用且尚未归还。经公司自查，并经 浙江复基控股集团有限公司（ ...

记者｜赵阳戈 2024年年报披露后，*ST中程（300208.SZ）收到了来自深交所的《终止上市事先告知书》，原因在于 公司2024年度财务会计报告被出具了保留意见的审计报告，以及内部控制被出具了否定意见的审计报 告。 值得注意的是，*ST中程对审计得出的结论并不认可，甚至指摘对方办事不力、推卸责任。如今公司已 在申请听证的路上。 源：公告 光伏项目上，审计在推卸责任？ 根据《终止上市事先告知书》内容，*ST中程曾因2023年度经审计的期末净资产为负值，被实施退市风 险警示。一年后的2025年4月30日，*ST中程2024年度财务会计报告被出具了保留意见的审计报告，内 部控制被出具了否定意见的审计报告。如此表现自是触发了终止上市的相关规则。 *ST中程与审计机构的争议的焦点之一在于菲律宾光伏项目。 *ST中程2016年11月承接菲律宾风光一体化EPC项目，2017年开始建设，至今近8年，截至2024年12月31 日，项目仍未交付并网。2025年4月15日，*ST中程向业主方移交菲律宾光伏项目并签署《风电(132兆 瓦)-光伏(100兆瓦)风光一体项目之结算协议》和《质押协议》，结算金额为2.12亿美元(按去年 ...